Monkeypox Emergency Clearance Excludes Siga’s Tpoxx Medicine (2)

The Biden administration’s decision to activate FDA emergency powers for monkeypox could quintuple the US vaccine supply, but the latest action doesn’t use that authority to boost treatment options.

HHS Secretary Xavier Becerra gave the Food and Drug Administration the green light to clear a technique that involves injecting smaller doses of the monkeypox vaccine into the upper layer of the skin. The emergency use authorization is limited to vaccines and doesn’t include therapeutics or testing.

“I was surprised to see that it just covers vaccines. I’m glad to see the declaration for vaccines. But there’s an urgent need for ...